Skip to main navigation
BioCryst Pharmaceuticals, Inc. Logo
  • Home
  • News & Events
    Press Releases Events & Presentations Media Materials
  • Stock
    Stock Quote & Chart Historic Stock Lookup Analyst Coverage
  • Corporate Governance
    Board of Directors Committee Composition Code of Conduct and Ethics Committee Charters Corporate Responsibility
  • Finance & Filings
    Financial Profile SEC Documents Proxy Online Quarterly Results
  • Investor Resources
    Investor FAQ Email Alerts RSS News Feeds

SEC Filing Details

Document Details

Form
8-K/A
Filing Date
Jan 23, 2026
Document Date
Oct 14, 2025
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
BioCryst Pharmaceuticals, Inc.
Issuer
BIOCRYST PHARMACEUTICALS INC

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL LABEL FILE
EX-101.PRE - XBRL PRESENTATION FILE
XML - XBRL INSTANCE DOCUMENT

Contact Investor Relations

investorrelations@biocryst.com

Investor Tools

  • Print Page
  • Printed Materials
  • Email Alerts
  • RSS News Feeds
  • Share Page
  • © BioCryst Pharmaceuticals, Inc. All Rights Reserved. 2026
  • Facebook
  • Twitter
  • LinkedIn
  • RSS